Abstract 1419: RCZY-711, a novel, highly potent, and orally bioavailable menin-MLL inhibitor with superior efficacy in preclinical acute leukemia models
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Chen Celia X.-J., Zhengyong Wan, Yu Bai, Xiaohong Liu, Jianming Bao
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409645183